506 Pharmaceutical composition for autosomal dominant polycystic kidney disease containing FK506 binding protein fusion protein

摘要

The present invention relates to a pharmaceutical composition for the prevention or treatment of autosomal dominant polycystic kidney, and more particularly, to a pharmaceutical composition for preventing or treating monocanthus, comprising a fusion protein of FK506 binding protein which is permeable to polycystic kidney cells, / RTI